Literature DB >> 1521979

Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma.

J Crane1, N Pearce, C Burgess, K Woodman, B Robson, R Beasley.   

Abstract

A case-control study has previously been reported of asthma deaths in people aged 5-45 years who had a hospital admission for asthma (the index admission) in New Zealand during 1981-1987. The study has been re-analysed to examine the association between markers of asthma severity and risk of asthma death or hospital admission; patients prescribed fenoterol were excluded from this re-analysis because of the previously reported interaction between fenoterol, asthma severity, and asthma deaths. The re-analysis included 39 patients who died of asthma during the 12 months after their index admission, 226 patients who had a readmission for asthma during the 12 months after their index admission, and 263 controls chosen from all index admissions. An admission in the previous 12 months was the strongest marker of subsequent risk of death (odds ratio (OR) = 3.5, 95% confidence interval (CI): 1.8-6.9, P less than 0.01), and was also a strong marker of subsequent risk of readmission (OR = 3.0, 95% CI: 2.1-4.2, P less than 0.01); the risk increased with the number of previous admissions. Three or more categories of prescribed asthma drugs was also associated with subsequent death (OR = 1.7, 95% CI: 0.9-3.3, P = 0.13) or readmission (OR = 1.9, 95% CI: 1.3-2.7, P less than 0.01); prescribed oral corticosteroids was only weakly associated with subsequent death (OR = 1.3, 95% CI: 0.6-2.8, P = 0.59), but was more strongly associated with subsequent readmission (OR = 1.9, 95% CI: 1.2-2.8, P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521979     DOI: 10.1093/ije/21.4.737

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  31 in total

1.  First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma.

Authors:  L Blais; S Suissa; J F Boivin; P Ernst
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

2.  Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma.

Authors:  S Suissa; P Ernst; A Kezouh
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

3.  The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes.

Authors:  J R Smith; S Mildenhall; M J Noble; L Shepstone; M Koutantji; M Mugford; B D W Harrison
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

Review 4.  Asthma exacerbations. 5: assessment and management of severe asthma in adults in hospital.

Authors:  Sarah Aldington; Richard Beasley
Journal:  Thorax       Date:  2007-05       Impact factor: 9.139

Review 5.  Management of acute asthma in adults in the emergency department: nonventilatory management.

Authors:  Rick Hodder; M Diane Lougheed; Brian H Rowe; J Mark FitzGerald; Alan G Kaplan; R Andrew McIvor
Journal:  CMAJ       Date:  2009-10-26       Impact factor: 8.262

6.  Case-control study of salmeterol and near-fatal attacks of asthma.

Authors:  C Williams; L Crossland; J Finnerty; J Crane; S Holgate; N Pearce; R Beasley
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

7.  Tailored education may reduce health literacy disparities in asthma self-management.

Authors:  Michael K Paasche-Orlow; Kristin A Riekert; Andrew Bilderback; Arjun Chanmugam; Peter Hill; Cynthia S Rand; Fred L Brancati; Jerry A Krishnan
Journal:  Am J Respir Crit Care Med       Date:  2005-08-04       Impact factor: 21.405

Review 8.  Asthma deaths and the athlete.

Authors:  David M Lang
Journal:  Clin Rev Allergy Immunol       Date:  2005-10       Impact factor: 8.667

Review 9.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

10.  Use of near fatal asthma for investigating asthma deaths.

Authors:  R Beasley; N Pearce; J Crane
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.